Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis

The causal protein of amyloid light‐chain (AL) amyloidosis is a monoclonal immunoglobulin free light chain (mFLC), which must be quantified in the serum for patient diagnosis and monitoring. Several manufacturers commercialize immunoassays that quantify total kappa (κ) and lambda (λ) FLC, but result...

Descripción completa

Detalles Bibliográficos
Autores principales: Abroud, Hajer, Beldi‐Ferchiou, Asma, Audard, Vincent, Lemonnier, François, Le Bras, Fabien, Belhadj, Karim, Moktefi, Anissa, Poullot, Elsa, El Karoui, Khalil, Dupuis, Jehan, Maarek, Alizée, Roulin, Louise, Delfau‐Larue, Marie‐Hélène, Oghina, Silvia, Kharoubi, Mounira, Bézard, Mélanie, Zaroui, Amira, Damy, Thibaud, Molinier‐Frenkel, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Haematologic Malignancy ‐ Plasma Cell
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421952/
https://www.ncbi.nlm.nih.gov/pubmed/36051065
http://dx.doi.org/10.1002/jha2.516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421952/
https://www.ncbi.nlm.nih.gov/pubmed/36051065
http://dx.doi.org/10.1002/jha2.516

Ejemplares similares